文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

CARDIOKIN1:健康对照与瓣膜病患者心肌代谢能力的计算评估

CARDIOKIN1: Computational Assessment of Myocardial Metabolic Capability in Healthy Controls and Patients With Valve Diseases.
PubMed 文献 · Circulation · 2021-11-11

研究开发了心脏能量代谢动力学模型CARDIOKIN1,利用左心室组织蛋白丰度个体化缩放最大酶活性,评估健康对照、主动脉瓣狭窄和二尖瓣关闭不全患者的左心室能量状态。结果显示两患者组静息ATP消耗增加、最大负荷ATP消耗降低,ATP产生储备下降,且能量状态与机械能量需求和心输出量紧密相关。

要点

  • 瓣膜病患者左心室ATP产生能力普遍降低,即使射血分数保留。
  • 最大负荷ATP消耗降低与心输出量降低相关,提示功能与能量紧密耦合。
  • 能量状态变异大,相似临床或影像学肥厚和泵功能指标的患者间差异明显。

核心结论

  • 瓣膜功能障碍患者左心室ATP产生能力普遍降低,且与机械能量需求和心输出量正相关。

研究设计与样本

  • 开发心脏能量代谢动力学模型CARDIOKIN1,用左心室组织蛋白丰度个体化缩放最大酶活性。
  • 评估健康对照、主动脉瓣狭窄和二尖瓣关闭不全患者的左心室能量状态。

主要发现

  • 与对照相比,两患者组静息ATP消耗增加、最大负荷ATP消耗降低,ATP产生储备下降。
  • 所有患者射血分数保留,但能量状态变异大,从降低到正常值不等。
  • 两患者组能量状态与机械能量需求紧密相关。
  • 最大负荷ATP消耗降低与心输出量降低相关。

临床怎么用

  • 基于生理的代谢模型结合蛋白丰度数据可用于无创评估心肌ATP产生能力。
  • 能量状态评估可能有助于理解瓣膜病发展及选择营养或药物治疗策略。

局限性

  • 原文未明确报告模型验证的局限性或样本量等具体限制信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many heart diseases can result in reduced pumping capacity of the heart muscle. A mismatch between ATP demand and ATP production of cardiomyocytes is one of the possible causes. Assessment of the relation between myocardial ATP production (MVATP) and cardiac workload is important for better understanding disease development and choice of nutritional or pharmacologic treatment strategies. Because there is no method for measuring MVATP in vivo, the use of physiology-based metabolic models in conjunction with protein abundance data is an attractive approach. METHOD: We developed a comprehensive kinetic model of cardiac energy metabolism (CARDIOKIN1) that recapitulates numerous experimental findings on cardiac metabolism obtained with isolated cardiomyocytes, perfused animal hearts, and in vivo studies with humans. We used the model to assess the energy status of the left ventricle of healthy participants and patients with aortic stenosis and mitral valve insufficiency. Maximal enzyme activities were individually scaled by means of protein abundances in left ventricle tissue samples. The energy status of the left ventricle was quantified by the ATP consumption at rest (MVATP[rest]), at maximal workload (MVATP[max]), and by the myocardial ATP production reserve, representing the span between MVATP(rest) and MVATP(max). RESULTS: Compared with controls, in both groups of patients, MVATP(rest) was increased and MVATP(max) was decreased, resulting in a decreased myocardial ATP production reserve, although all patients had preserved ejection fraction. The variance of the energetic status was high, ranging from decreased to normal values. In both patient groups, the energetic status was tightly associated with mechanic energy demand. A decrease of MVATP(max) was associated with a decrease of the cardiac output, indicating that cardiac functionality and energetic performance of the ventricle are closely coupled. CONCLUSIONS: Our analysis suggests that the ATP-producing capacity of the left ventricle of patients with valvular dysfunction is generally diminished and correlates positively with mechanical energy demand and cardiac output. However, large differences exist in the energetic state of the myocardium even in patients with similar clinical or image-based markers of hypertrophy and pump function. Registration: URL: https://www.clinicaltrials.gov; Unique identifiers: NCT03172338 and NCT04068740.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Berndt N, Eckstein J, Wallach I, et al. CARDIOKIN1: Computational Assessment of Myocardial Metabolic Capability in Healthy Controls and Patients With Valve Diseases. Circulation. 2021. PMID: 34762513. doi:10.1161/CIRCULATIONAHA.121.055646

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。